Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study.
Neurol Sci
; 45(4): 1661-1668, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-37926748
Full text:
1
Database:
MEDLINE
Main subject:
Hypertension
/
Antibodies, Monoclonal
Limits:
Humans
Language:
En
Journal:
Neurol Sci
Journal subject:
NEUROLOGIA
Year:
2024
Type:
Article
Affiliation country:
Italy